new drug skin cancer
Trial results show that the one-course infusion treatment can significantly extend the survival of patients with advanced melanoma, the deadliest form of the disease.
Some patients who might otherwise have died in weeks or months have had years of extra life.
At least one is still alive five years after receiving the treatment, and gives the impression of being "cured".
